» Articles » PMID: 2411948

Capsid Intermediates Assembled in a Foot-and-mouth Disease Virus Genome RNA-programmed Cell-free Translation System and in Infected Cells

Overview
Journal J Virol
Date 1985 Oct 1
PMID 2411948
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Structural protein complexes sedimenting at 140S, 70S (empty capsids), and 14S were isolated from foot-and-mouth disease virus-infected cells. The empty capsids were stable, while 14S complexes were relatively short-lived. Radioimmune binding assays involving the use of neutralizing monoclonal antibodies to six distinct epitopes on type A12 virus and polyclonal antisera to A12 structural proteins demonstrated that native empty capsids were indistinguishable from virus. Infected cell 14S particles possessed all the neutralizing epitopes and reacted with VP2 antiserum. Cell-free structural protein complexes sedimenting at 110S, 60S, and 14S containing capsid proteins VP0, VP3, and VP1 are assembled in a rabbit reticulocyte lysate programmed with foot-and-mouth viral RNA. These structures also contain the six epitopes, and cell-free 14S structures like their in vivo counterparts reacted with VP2 antiserum. Capsid structures from infected cells and the cell-free complexes adsorbed to susceptible cells, and this binding was inhibited, to various degrees, by saturating levels of unlabeled virus. These assays and other biochemical evidence indicate that capsid assembly in the cell-free system resembles viral morphogenesis in infected cells. In addition, epitopes on the virus surface possibly involved in interaction with cellular receptor sites are found early in virion morphogenesis.

Citing Articles

Foot-and-mouth disease in Asia.

Rahman M, Zereen F, Rana M, Hossain M, Shimada M, Saha S Virus Res. 2024; 351:199514.

PMID: 39689813 PMC: 11770323. DOI: 10.1016/j.virusres.2024.199514.


Expression of virus-like particles (VLPs) of foot-and-mouth disease virus (FMDV) using Saccharomyces cerevisiae.

Le N, So K, Chun J, Kim D Appl Microbiol Biotechnol. 2024; 108(1):81.

PMID: 38194136 PMC: 10776484. DOI: 10.1007/s00253-023-12902-9.


Evaluation of DNA Vaccine Candidates against Foot-and-Mouth Disease Virus in Cattle.

Puckette M, Clark B, Barrera J, Neilan J, Rasmussen M Vaccines (Basel). 2023; 11(2).

PMID: 36851264 PMC: 9960313. DOI: 10.3390/vaccines11020386.


Foot-and-Mouth Disease Virus: Molecular Interplays with IFN Response and the Importance of the Model.

Sarry M, Vitour D, Zientara S, Bakkali Kassimi L, Blaise-Boisseau S Viruses. 2022; 14(10).

PMID: 36298684 PMC: 9610432. DOI: 10.3390/v14102129.


Effect of Foot-and-Mouth Disease Virus 2B Viroporin on Expression and Extraction of Mammalian Cell Culture Produced Foot-and-Mouth Disease Virus-like Particles.

Primavera V, Simmons J, Clark B, Neilan J, Puckette M Vaccines (Basel). 2022; 10(9).

PMID: 36146583 PMC: 9502367. DOI: 10.3390/vaccines10091506.


References
1.
Bachrach H, Moore D, McKERCHER P, Polatnick J . Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. J Immunol. 1975; 115(6):1636-41. View

2.
Bahnemann H . Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production. Arch Virol. 1975; 47(1):47-56. DOI: 10.1007/BF01315592. View

3.
McGregor S, Rueckert R . Picornaviral capsid assembly: similarity of rhinovirus and enterovirus precursor subunits. J Virol. 1977; 21(2):548-53. PMC: 353856. DOI: 10.1128/JVI.21.2.548-553.1977. View

4.
Lund G, Ziola B, Salmi A, Scraba D . Structure of the Mengo virion. V. Distribution of the capsid polypeptides with respect to the surface of the virus particle. Virology. 1977; 78(1):35-44. DOI: 10.1016/0042-6822(77)90076-9. View

5.
Rweyemamu M, Terry G, PAY T . Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Arch Virol. 1979; 59(1-2):69-79. DOI: 10.1007/BF01317896. View